MARKET

RVNC

RVNC

Revance
NASDAQ

Real-time Quotes | Nasdaq Last Sale

13.52
+0.92
+7.30%
Opening 12:49 04/02 EDT
OPEN
12.79
PREV CLOSE
12.60
HIGH
13.53
LOW
12.52
VOLUME
209.44K
TURNOVER
--
52 WEEK HIGH
27.97
52 WEEK LOW
9.88
MARKET CAP
771.05M
P/E (TTM)
-3.6921
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 12 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average RVNC stock price target is 35.20 with a high estimate of 55.00 and a low estimate of 15.00.

EPS

RVNC News

More
  • Mizuho Maintains Buy on Revance Therapeutics, Lowers Price Target to $35
  • Benzinga · 1d ago
  • Revance Provides Corporate Update in Light of COVID-19
  • Business Wire · 6d ago
  • Implied Volatility Surging for Revance Therapeutics (RVNC) Stock Options
  • Zacks · 03/25 12:36
  • SocGen cuts view on AbbVie in premarket analyst action
  • Seeking Alpha - Article · 03/23 10:58

Industry

Biotechnology & Medical Research
+2.20%
Pharmaceuticals & Medical Research
+1.73%

Hot Stocks

Symbol
Price
%Change

About RVNC

Revance Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on the development, manufacturing and commercialization of botulinum toxin products for multiple aesthetic and therapeutic indications. Its peptide technology enables delivery of botulinum toxin type A through two investigational drug product candidates, DaxibotulinumtoxinA for Injection (RT002), or RT002 injectable, and DaxibotulinumtoxinA Topical Gel (RT001), or RT001 topical. It is engaged in the clinical development for RT002 injectable. RT002 injectable utilizes botulinum toxin-peptide complex in a saline-based formulation. In RT002 injectable, the peptide interacts with both extracellular structures and cell surface receptors in the targeted muscle. This interaction restricts the toxin molecule to the target site and reduces unwanted spread to other neighboring muscles. It is focusing on developing RT002 for the treatment of glabellar lines, cervical dystonia and plantar fasciitis.
More

Webull offers kinds of Revance Therapeutics Inc stock information, including NASDAQ:RVNC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RVNC stock news, and many more online research tools to help you make informed decisions.